Big News: FDA is moving from MasterControl to ComplianceQuest.See Why
Talk to a SpecialistLoading…
Talk to a SpecialistTalk to a SpecialistBased on limited metadata available, this warning letter was issued to Paramesh Banerji Life Sciences, LLC in August 2018 regarding an unspecified product category classified as "Other." Without access to the full letter text or detailed subject information, the specific regulatory violations cannot be determined; however, the warning indicates FDA identified compliance concerns serious enough to warrant formal enforcement action. The issuing office is not identified in the available metadata, limiting visibility into which FDA division oversaw this matter. To understand the full scope and nature of violations, the complete warning letter would need to be reviewed.